Literature DB >> 3654974

Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.

A A Portale1, B P Halloran, R C Morris.   

Abstract

We recently reported that in healthy men, changes in the production rate (PR) of 1,25-dihydroxyvitamin D [1,25-(OH)2D] accounted for the 80% increase and the 30% decrease in its serum concentration that was induced by restriction and supplementation, respectively, of dietary phosphorus. These changes in PR and serum concentration of 1,25-(OH)2D could be mediated by changes in serum concentrations of phosphorus that occur after the morning fasting period. To examine this hypothesis, we measured serum concentrations of phosphorus in blood drawn at hourly intervals for 24 h in six healthy men in whom dietary phosphorus was initially maintained at 1,500 mg/70 kg body weight per day for 9 d, then restricted to 500 mg/d (coupled with orally administered aluminum hydroxide) for 10 d, and then supplemented to 3,000 mg/d for 10 d. When dietary phosphorus was normal, the serum concentration of phosphorus exhibited the normal circadian rhythm: a rapid decrease in early morning to a nadir at 1100, followed by an increase to plateau at 1600 h and a further increase to an acrophase (peak) at 0030 h. The variation in serum levels of phosphorus can be described as the sum of sinusoidal functions with periodicities of 24 and 12 h. Phosphorus restriction for 10 d induced a 40% reduction in the 24-h mean serum level of phosphorus, abolished the early afternoon rise in its serum level (i.e., the 12-h periodic component of the time series), and delayed the acrophase by 3 h to 0330 h. Phosphorus supplementation for 10 d induced a 14% increase in the 24-h mean serum level of phosphorus but no significant change in its morning fasting level, exaggerated the early afternoon rise in serum phosphorus, and advanced the acrophase by 9 h to 1530 h. The changes in the PR of 1,25-(OH)2D induced by restriction and supplementation of dietary phosphorus varied inversely and significantly with those induced in the 24-h mean serum level of phosphorus (R = -0.88, P less than 0.001). These data demonstrate that in healthy men, dietary phosphorus is an important determinant of the serum concentration of phosphorus throughout most of the day. The data suggest that diet-induced changes in serum levels of phosphorus mediate the changes in PR and serum concentration of 1,25(OH)2D.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654974      PMCID: PMC442358          DOI: 10.1172/JCI113172

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

2.  Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo.

Authors:  H L Henry; R J Midgett; A W Norman
Journal:  J Biol Chem       Date:  1974-12-10       Impact factor: 5.157

3.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

4.  Diurnal variation in serum and urine electrolytes.

Authors:  M Buchsbaum; E K Harris
Journal:  J Appl Physiol       Date:  1971-01       Impact factor: 3.531

5.  Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy.

Authors:  R W Gray
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

6.  Growth hormone and triiodothyronine permit an increase in plasma 1,25(OH)2D concentrations in response to dietary phosphate deprivation in hypophysectomized rats.

Authors:  R W Gray; T L Garthwaite; L S Phillips
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

7.  Site of 1,25(OH)2 vitamin D3 synthesis in the kidney.

Authors:  M G Brunette; M Chan; C Ferriere; K D Roberts
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

8.  Phosphate deprivation increases serum 1,25-(OH)2-vitamin D concentrations in healthy men.

Authors:  W J Maierhofer; R W Gray; J Lemann
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

9.  Serum concentration of 1,25-dihydroxyvitamin D in the human: diurnal variation.

Authors:  B P Halloran; A A Portale; M Castro; R C Morris; R S Goldsmith
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

10.  Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.

Authors:  C J Van Den Berg; R Kumar; D M Wilson; H Heath; L H Smith
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

View more
  55 in total

1.  Evaluation of hypophosphatemia: lessons from patients with genetic disorders.

Authors:  Justine Bacchetta; Isidro B Salusky
Journal:  Am J Kidney Dis       Date:  2011-11-09       Impact factor: 8.860

2.  Relationship between timed and spot urine collections for measuring phosphate excretion.

Authors:  Sven-Jean Tan; Edward R Smith; Michael M X Cai; Stephen G Holt; Tim D Hewitson; Nigel D Toussaint
Journal:  Int Urol Nephrol       Date:  2015-11-14       Impact factor: 2.370

3.  Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Authors:  Sharon M Moe; Miriam P Zidehsarai; Mary A Chambers; Lisa A Jackman; J Scott Radcliffe; Laurie L Trevino; Susan E Donahue; John R Asplin
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 8.237

Review 4.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

5.  Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 6.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28

7.  Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; Tessa C Rue; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2008-11-06       Impact factor: 8.860

8.  Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis.

Authors:  Alvaro Alonso; Jennifer A Nettleton; Joachim H Ix; Ian H de Boer; Aaron R Folsom; Aurelian Bidulescu; Bryan R Kestenbaum; Lloyd E Chambless; David R Jacobs
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

9.  Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.

Authors:  Alex R Chang; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2014-06-14       Impact factor: 8.860

10.  24-hour urine phosphorus excretion and mortality and cardiovascular events.

Authors:  Heather L Palomino; Dena E Rifkin; Cheryl Anderson; Michael H Criqui; Mary A Whooley; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.